Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 323

1.

Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217).

Gritz ER, Arnold KB, Moinpour CM, Burton-Chase AM, Tangen CM, Probstfield JF, See WA, Lieber MM, Caggiano V, Moody-Thomas S, Szczepanek C, Ryan A, Carlin S, Hill S, Goodman PJ, Padberg RM, Minasian LM, Meyskens FL, Thompson IM Jr.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1638-48. doi: 10.1158/1055-9965.EPI-14-0202. Epub 2014 Jul 15.

2.

Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health Study.

Sarma AV, St Sauver JL, Jacobson DJ, McGree ME, Klee GG, Lieber MM, Girman CJ, Hollingsworth JM, Jacobsen SJ; Urologic Diseases in America Project.

Urology. 2014 Jan;83(1):88-93. doi: 10.1016/j.urology.2013.08.025. Epub 2013 Oct 16.

4.

Effectiveness of medical and surgical therapies for lower urinary tract symptoms in the community setting.

Krambeck AE, Jacobson DJ, McGree ME, Lightner DJ, Lieber MM, Jacobsen SJ, St Sauver JL.

BJU Int. 2012 Nov;110(9):1332-7. doi: 10.1111/j.1464-410X.2012.10998.x. Epub 2012 Apr 3.

5.

Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men.

Rhodes T, Jacobson DJ, McGree ME, St Sauver JL, Girman CJ, Lieber MM, Klee GG, Demissie K, Jacobsen SJ.

Urology. 2012 Mar;79(3):655-61. doi: 10.1016/j.urology.2011.09.056.

6.

Nocturia is associated with an increased risk of coronary heart disease and death.

Lightner DJ, Krambeck AE, Jacobson DJ, McGree ME, Jacobsen SJ, Lieber MM, Roger VL, Girman CJ, St Sauver JL.

BJU Int. 2012 Sep;110(6):848-53. doi: 10.1111/j.1464-410X.2011.10806.x. Epub 2012 Jan 10.

7.

Sixteen-year longitudinal changes in serum prostate-specific antigen levels: the olmsted county study.

Jacobsen SJ, Jacobson DJ, McGree ME, St Sauver JL, Klee GG, Girman CJ, Lieber MM.

Mayo Clin Proc. 2012 Jan;87(1):34-40. doi: 10.1016/j.mayocp.2011.09.002.

8.

Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men.

Sarma AV, St Sauver JL, Hollingsworth JM, Jacobson DJ, McGree ME, Dunn RL, Lieber MM, Jacobsen SJ; Urologic Diseases in America Project.

Urology. 2012 Jan;79(1):102-8. doi: 10.1016/j.urology.2011.08.065. Epub 2011 Nov 23.

9.

Benign prostate specific antigen distribution and associations with urological outcomes in community dwelling black and white men.

Rhodes T, Jacobson DJ, McGree ME, St Sauver JL, Sarma AV, Girman CJ, Lieber MM, Klee GG, Demissie K, Jacobsen SJ.

J Urol. 2012 Jan;187(1):87-91. doi: 10.1016/j.juro.2011.09.061. Epub 2011 Nov 16.

10.

Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white men.

Rhodes T, Jacobson DJ, McGree ME, St Sauver JL, Sarma AV, Girman CJ, Lieber MM, Klee GG, Demissie K, Jacobsen SJ.

J Urol. 2012 Jan;187(1):92-6. doi: 10.1016/j.juro.2011.09.060. Epub 2011 Nov 16.

11.

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH.

JAMA. 2011 Oct 12;306(14):1549-56. doi: 10.1001/jama.2011.1437.

12.

Associations between modest weight changes and onset and progression of lower urinary tract symptoms in two population-based cohorts.

St Sauver JL, Sarma AV, Hollingsworth JM, Jacobson DJ, McGree ME, Dunn RL, Lieber MM, Jacobsen SJ; Urologic Diseases in America Project.

Urology. 2011 Aug;78(2):437-41. doi: 10.1016/j.urology.2011.03.054. Epub 2011 Jun 15.

13.

Fracture risk in men with prostate cancer: a population-based study.

Melton LJ 3rd, Lieber MM, Atkinson EJ, Achenbach SJ, Zincke H, Therneau TM, Khosla S.

J Bone Miner Res. 2011 Aug;26(8):1808-15. doi: 10.1002/jbmr.405.

14.

Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.

St Sauver JL, Lieber MM, Slager SL, Jacobson DJ, McGree ME, Jacobsen SJ.

BJU Int. 2011 Nov;108(10):1610-5. doi: 10.1111/j.1464-410X.2011.10161.x. Epub 2011 Apr 11.

15.

Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes.

St Sauver JL, Jacobson DJ, McGree ME, Girman CJ, Klee GG, Lieber MM, Jacobsen SJ.

Am J Epidemiol. 2011 Apr 1;173(7):787-96. doi: 10.1093/aje/kwq438. Epub 2011 Mar 2.

16.

Measures of autonomic nervous system activity and lower urinary tract symptoms.

St Sauver JL, Sandroni P, Jacobson DJ, McGree ME, Lieber MM, Jacobsen SJ.

Clin Auton Res. 2011 Feb;21(1):61-4. doi: 10.1007/s10286-010-0086-2. Epub 2010 Sep 16.

17.

Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms.

St Sauver JL, Jacobsen SJ, Jacobson DJ, McGree ME, Girman CJ, Nehra A, Roger VL, Lieber MM.

BJU Int. 2011 Feb;107(3):443-50. doi: 10.1111/j.1464-410X.2010.09598.x. Epub 2010 Aug 26.

18.

Estimation of prostate size in community-dwelling men.

Jacobson DJ, St Sauver JL, Parker AS, McGree ME, Sarma AV, Girman CJ, Lieber MM, Jacobsen SJ.

Urology. 2011 Feb;77(2):422-6. doi: 10.1016/j.urology.2010.05.044. Epub 2010 Aug 30.

19.

The association between statin use and the diagnosis of prostate cancer in a population based cohort.

Breau RH, Karnes RJ, Jacobson DJ, McGree ME, Jacobsen SJ, Nehra A, Lieber MM, St Sauver JL.

J Urol. 2010 Aug;184(2):494-9. doi: 10.1016/j.juro.2010.03.149. Epub 2010 Jun 17.

20.

Intravesical prostatic protrusion in men in Olmsted County, Minnesota.

Lieber MM, Jacobson DJ, McGree ME, St Sauver JL, Girman CJ, Jacobsen SJ.

J Urol. 2009 Dec;182(6):2819-24. doi: 10.1016/j.juro.2009.08.086. Epub 2009 Oct 17.

21.

Three-dimensional ultrasound bladder characteristics and their association with prostate size and lower urinary tract dysfunction among men in the community.

Rule AD, St Sauver JL, Jacobson DJ, McGree ME, Girman CJ, Lieber MM, Jacobsen SJ.

Urology. 2009 Oct;74(4):908-13. doi: 10.1016/j.urology.2009.04.081. Epub 2009 Aug 3.

22.

Natural history of benign prostatic enlargement: long-term longitudinal population-based study of prostate volume doubling times.

Lieber MM, Rhodes T, Jacobson DJ, McGree ME, Girman CJ, Jacobsen SJ, St Sauver JL.

BJU Int. 2010 Jan;105(2):214-9. doi: 10.1111/j.1464-410X.2009.08719.x. Epub 2009 Jul 7.

23.

Longitudinal evaluation of sexual function in a male cohort: the Olmsted county study of urinary symptoms and health status among men.

Gades NM, Jacobson DJ, McGree ME, St Sauver JL, Lieber MM, Nehra A, Girman CJ, Jacobsen SJ.

J Sex Med. 2009 Sep;6(9):2455-66. doi: 10.1111/j.1743-6109.2009.01374.x. Epub 2009 Jun 29.

24.

Alpha-blocker use is associated with decreased risk of sexual dysfunction.

Kumar R, Nehra A, Jacobson DJ, McGree ME, Gades NM, Lieber MM, Jacobsen SJ, St Sauver JL.

Urology. 2009 Jul;74(1):82-7. doi: 10.1016/j.urology.2008.12.080. Epub 2009 May 9.

25.

Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.

St Sauver JL, Sarma AV, Jacobson DJ, McGree ME, Lieber MM, Girman CJ, Nehra A, Jacobsen SJ.

Am J Epidemiol. 2009 Jun 1;169(11):1281-90. doi: 10.1093/aje/kwp085. Epub 2009 Apr 24.

26.

Presumed circle area ratio of the prostate in a community-based group of men.

St Sauver JL, Jacobson DJ, McGree ME, Girman CJ, Nehra A, Lieber MM, Jacobsen SJ.

BJU Int. 2009 Jul;104(1):58-62. doi: 10.1111/j.1464-410X.2009.08354.x. Epub 2009 Feb 11.

27.

A population-based, longitudinal study of erectile dysfunction and future coronary artery disease.

Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM, Roger VL, Jacobsen SJ.

Mayo Clin Proc. 2009 Feb;84(2):108-13. doi: 10.4065/84.2.108.

28.

Smoking and acute urinary retention: the Olmsted County study of urinary symptoms and health status among men.

Sarma AV, Jacobson DJ, St Sauver JL, Lieber MM, Girman CJ, Nehra A, Jacobsen SJ.

Prostate. 2009 May 15;69(7):699-705. doi: 10.1002/pros.20914.

29.

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr.

JAMA. 2009 Jan 7;301(1):39-51. doi: 10.1001/jama.2008.864. Epub 2008 Dec 9.

30.

Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County study.

Wallner LP, Sarma AV, Lieber MM, St Sauver JL, Jacobson DJ, McGree ME, Gowan ME, Jacobsen SJ.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3588-92. doi: 10.1158/1055-9965.EPI-08-0050.

31.

The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County Study of Urinary Symptoms and Health Status among Men.

Gades NM, Jacobson DJ, McGree ME, St Sauver JL, Lieber MM, Nehra A, Girman CJ, Klee GG, Jacobsen SJ.

J Sex Med. 2008 Sep;5(9):2209-20. doi: 10.1111/j.1743-6109.2008.00924.x. Epub 2008 Jul 4.

32.

Longitudinal association between prostatitis and development of benign prostatic hyperplasia.

St Sauver JL, Jacobson DJ, McGree ME, Girman CJ, Lieber MM, Jacobsen SJ.

Urology. 2008 Mar;71(3):475-9; discussion 479. doi: 10.1016/j.urology.2007.11.155.

33.

Snoring as a risk factor for sexual dysfunction in community men.

Hanak V, Jacobson DJ, McGree ME, Sauver JS, Lieber MM, Olson EJ, Somers VK, Gades NM, Jacobsen SJ.

J Sex Med. 2008 Apr;5(4):898-908. doi: 10.1111/j.1743-6109.2007.00706.x. Epub 2007 Dec 17.

34.

Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men.

Sarma AV, Burke JP, Jacobson DJ, McGree ME, St Sauver J, Girman CJ, Lieber MM, Herman W, Macoska J, Montie JE, Jacobsen SJ.

Diabetes Care. 2008 Mar;31(3):476-82. Epub 2007 Dec 10.

PMID:
18071006
35.

Population-based case-control study of PSA and DRE screening on prostate cancer mortality.

Bergstralh EJ, Roberts RO, Farmer SA, Slezak JM, Lieber MM, Jacobsen SJ.

Urology. 2007 Nov;70(5):936-41.

36.

Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men.

Burke JP, Jacobson DJ, McGree ME, Nehra A, Roberts RO, Girman CJ, Lieber MM, Jacobsen SJ.

J Urol. 2007 Apr;177(4):1438-42.

PMID:
17382749
37.

Bacteriophage research: its deeper significance for science.

Lieber MM.

Riv Biol. 2006 May-Aug;99(2):224-6. No abstract available.

PMID:
17183765
38.

Dropout in a longitudinal, cohort study of urologic disease in community men.

Gades NM, Jacobson DJ, McGree ME, Lieber MM, Roberts RO, Girman CJ, Jacobsen SJ.

BMC Med Res Methodol. 2006 Dec 14;6:58.

39.

Radical prostatectomy for octogenarians: how old is too old?

Thompson RH, Slezak JM, Webster WS, Lieber MM.

Urology. 2006 Nov;68(5):1042-5. Epub 2006 Nov 7.

PMID:
17095073
40.

Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia.

St Sauver JL, Jacobson DJ, McGree ME, Lieber MM, Jacobsen SJ.

Am J Epidemiol. 2006 Oct 15;164(8):760-8. Epub 2006 Aug 11.

PMID:
16905643
41.
42.

Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia.

Burke JP, Rhodes T, Jacobson DJ, McGree ME, Roberts RO, Girman CJ, Lieber MM, Jacobsen SJ.

Am J Epidemiol. 2006 Jul 1;164(1):41-6. Epub 2006 Apr 12.

PMID:
16611664
43.

PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer.

Vanaja DK, Ballman KV, Morlan BW, Cheville JC, Neumann RM, Lieber MM, Tindall DJ, Young CY.

Clin Cancer Res. 2006 Feb 15;12(4):1128-36.

44.

Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort.

St Sauver JL, Jacobson DJ, Girman CJ, Lieber MM, McGree ME, Jacobsen SJ.

J Urol. 2006 Mar;175(3 Pt 1):1018-22; discussion 1022.

PMID:
16469608
45.

Correlations between longitudinal changes in transitional zone volume and measures of benign prostatic hyperplasia in a population-based cohort.

St Sauver JL, Jacobson DJ, Girman CJ, McGree ME, Lieber MM, Jacobsen SJ.

Eur Urol. 2006 Jul;50(1):105-11. Epub 2006 Jan 20.

PMID:
16466847
46.

Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men.

Mullan RJ, Bergstralh EJ, Farmer SA, Jacobson DJ, Hebbring SJ, Cunningham JM, Thibodeau SN, Lieber MM, Jacobsen SJ, Roberts RO.

Urology. 2006 Feb;67(2):300-5.

PMID:
16461080
47.

Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota.

Burke JP, Jacobson DJ, McGree ME, Roberts RO, Girman CJ, Lieber MM, Jacobsen SJ.

Urology. 2006 Jan;67(1):22-5.

PMID:
16413325
48.

Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia.

Roberts RO, Bergstralh EJ, Farmer SA, Jacobson DJ, Hebbring SJ, Cunningham JM, Thibodeau SN, Lieber MM, Jacobsen SJ.

Prostate. 2006 Mar 1;66(4):392-404.

PMID:
16302261
49.

Longitudinal changes in post-void residual and voided volume among community dwelling men.

Rule AD, Jacobson DJ, McGree ME, Girman CJ, Lieber MM, Jacobsen SJ.

J Urol. 2005 Oct;174(4 Pt 1):1317-21; discussion 1321-2; author reply 1322.

PMID:
16145411
50.

Cross-sectional associations of urogenital pain and sexual function in a community based cohort of older men: olmsted county, Minnesota.

Lutz MC, Roberts RO, Jacobson DJ, McGree ME, Lieber MM, Jacobsen SJ.

J Urol. 2005 Aug;174(2):624-8; discussion 628.

PMID:
16006925

Supplemental Content

Loading ...
Support Center